Navigation Links
National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
Date:2/19/2009

INDIANAPOLIS, LOS ANGELES, SOUTH SAN FRANCISCO, Calif., WASHINGTON, Feb. 19 /PRNewswire/ -- Tens of thousands of people surviving a cancer diagnosis may benefit from a new program being introduced today by a collaboration of health care providers, patient advocates, health benefit insurers and a biotechnology company.

Journey Forward ( www.JourneyForward.org ), which is launching as a pilot program in California, Colorado, Maine, Nevada and New Hampshire, promotes physician and patient understanding of the post-treatment effects of cancer. By facilitating the development of a survivorship care plan, the program aims to improve continuity and coordination of care for cancer survivors throughout their lives.

This first-of-its-kind program was created in response to recommendations by the independent Institute of Medicine (IOM), which concluded in a November 2005 report that "the consequences of cancer and its treatment are substantial" and largely unmet. The report says many cancer survivors are "lost in transition" from active treatment to survivorship, with few clues about how to manage their follow-up care and about the physical and mental health problems that may result from their treatment.

"Patients often have no idea what to expect once they've finished their cancer treatment, and neither do the primary care providers on their team," said Dr. Patricia Ganz, director of the UCLA Cancer Survivorship Center and a nationally renowned expert on survivorship. "There is a need for better post-treatment coordination of care and the treatment summary and survivorship care plan is a place to start. Survivors often don't know what kind of surveillance and follow-up care they need to monitor for disease recurrence or any late effects that may result from their cancer treatment."

"By providing tools and information to both parties, Journey Forward opens the door for improved dialogue between physicians and patients and promotes the coordination of long-term care for people with cancer. It also gives survivors a greater opportunity to participate in their care," said Ellen Stovall, a three-time cancer survivor and acting president & CEO of the National Coalition for Cancer Survivorship.

Journey Forward, a collaboration among National Coalition for Cancer Survivorship (NCCS), the UCLA Cancer Survivorship Center, WellPoint, Inc. and Genentech, will distribute kits to health care providers and patients that explain the importance of follow-up care plans, offer tools for providers to generate these plans and offer interactive tools for patients to participate in the process. The kits, which are also available online at www.JourneyForward.org , are tailored to oncologists, patients and primary care physicians. Journey Forward will initially focus on survivors of breast and colon cancers as well as oncologists and primary care providers. The program will later expand to target additional providers and survivors of additional cancer types throughout the country.

"WellPoint is committed to working with other health care partners to develop innovative programs and services that improve the health of our communities and consumers," said Angela F. Braly, president and CEO, WellPoint, Inc. "Through collaborative efforts like Journey Forward, we can help physicians, members and insurers work together toward short-term and long-term treatment plans that help ensure the most appropriate health care services for each patient."

David Schenkein, M.D., Genentech's senior vice president, Clinical Oncology and Hematology, adds: "Improved diagnostic testing and new personalized cancer medicines have helped many people live longer lives. Journey Forward can help ensure that, after a person completes their initial cancer treatment, they continue to get the best possible care as they begin to rebuild their life."

National Coalition for Cancer Survivorship

The National Coalition for Cancer Survivorship (NCCS) advocates for quality cancer care for all Americans and provides tools that empower people affected by cancer to advocate for themselves. Founded by and for cancer survivors in 1986, NCCS created the widely-accepted definition of survivorship and considers someone a cancer survivor from the time of diagnosis through the balance of life. Its free publications and resources include the award-winning Cancer Survival Toolbox(R), a self-learning audio program created by leading cancer organizations to help people develop essential skills to meet the challenges of their illness. More information is available at www.canceradvocacy.org or 1-888-650-9127.

UCLA Cancer Survivorship Center

The UCLA Cancer Survivorship Center's mission is to provide high quality clinical care for post-treatment cancer patients, provide information on improving survivorship quality-of-life, pursue cutting-edge survivorship research and educate the community on survivorship care and concerns. The center has become the focal point of survivorship activities at UCLA's Jonsson Comprehensive Cancer Center and UCLA Healthcare. The center is developing models of health care delivery to meet the physical and psychosocial needs of cancer survivors.

WellPoint, Inc.

WellPoint (NYSE: WLP) is committed to improving the lives and health of the people and communities we serve by simplifying the connection between health, care and value. Our goal is to help shape the impact each health care decision has on individuals, the health care system at-large, and our communities. WellPoint's more than 42,000 associates work every day to help create the best health care value for our customers. Through collaborations with providers and with innovative programs, WellPoint's affiliated health plans reward healthy lifestyles and quality, safe and effective care. As the nation's largest health benefits company, with more than 35 million members in its affiliated health plans, WellPoint is at the center of the health care system. This position provides us with the relationships and insights needed to help create affordable and actionable solutions that improve health care.

As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at www.wellpoint.com .

Genentech

Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines for patients with significant unmet medical needs. The company has headquarters in South San Francisco, California and is listed on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit http://www.gene.com .


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
2. National Health Care List Ranks McLaren Health Care Top in Michigan; 16th in Nation
3. Osteotech Receives 13485:2003 ISO Certification; Company Meets International Standards for Medical Device Manufacturing
4. National Committee For Quality Assurance (NCQA) Awards MVP Health Care Excellent Accreditation Status For Its HMO/POS Plan
5. IOF joins ECCEO9 at leading international meeting in Athens
6. Remuda Ranch Seeks to Increase Awareness of Eating Disorders Among Males During National Eating Disorders Awareness Week (NEDAW), February 22-28, 2009
7. National Dental Insurer United Concordia Successfully Launches Real-Time Claims Processing with Tesia-PCI
8. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
9. HUYA Bioscience International Announces Collaboration Agreement With the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
10. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
11. Quantros President Appears on National TV Promoting Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... Petaluma, CA (PRWEB) , ... August 16, 2017 ... ... donate and distribute $100,000 in AED (Automated External Defibrillator) machines to their local ... an AED device from Arrow Benefits Group. AED machines are an integral part ...
(Date:8/16/2017)... ... ... of A Child” is the creation of published author, Pauline DiBenedetto. , “As my mother ... was in such great pain, my mother thought that her time has come. Once I ... I was about eight years old, when I had a vision of my own, that ...
(Date:8/15/2017)... Los Angeles, CA (PRWEB) , ... August 15, 2017 , ... The city of Los ... styles exist in harmony with “Cali Style”. LA’s Top Style List, a website that spotlights ... to help the public wear their wardrobe all year long. , According to the senior ...
(Date:8/15/2017)... ... August 15, 2017 , ... The V Foundation ... 19th Annual V Foundation Wine Celebration raised nearly $9 million for cancer research ... million in “Fund-A-Need” donations to support the study of BRCA mutation research in ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
(Date:7/26/2017)... Fla. , July 26, 2017 Sancilio ... enrollment of our clinical trial evaluating Altemia TM , ... Anemia (SCA) and Sickle Cell Disease (SCD). The SCOT ... evaluate the efficacy and safety of Altemia TM ... is conducted under US IND 125274. ...
(Date:7/24/2017)... N.Y. , July 24, 2017 IBM (NYSE: ... the Gartner Magic Quadrant for Solid-State Arrays (SSA) for the ... According to Gartner, "Vendors in the Leaders ... and Completeness of Vision. A vendor in the Leaders quadrant ... needed to drive the acceptance of new technologies. These vendors ...
Breaking Medicine Technology: